# Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.

> **NCT00154011** · NA · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 24 (—)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** rosiglitazone (drug)

## Key facts

- **NCT ID:** NCT00154011
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 24 (—)
- **Last updated:** 2006-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154011, "Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00154011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*